Andere talen Krystal Biotech, Inc.

Aandelen

KRYS

US5011471027

Geschatte realtime Cboe BZX Andere beurzen 21:01:54 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
159,6 ^USD	+4,21%		-0,75%	+27,24%

22/04	Krystal Biotech, Inc. kondigt aan dat de eerste patiënt is gedoseerd in het Fase 1 klinische onderzoek naar geïnhaleerd KB707 voor de behandeling van lokaal gevorderde of gemetastaseerde solide longtumoren	CI
16/04	KRYSTAL BIOTECH, INC. : Stifel Nicolaus herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	26/04
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22/04
Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22/04
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05/04
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04/04
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29/02
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	28/02
Sector Update: Health Care Stocks Ease Late Afternoon	26/02
Sector Update: Health Care Stocks Weaker Monday Afternoon	26/02
Top Midday Gainers	26/02
Krystal Biotech Shares Jump After Surprise Q4 Profit	26/02
Krystal Biotech Swings to Q4 Profit as Company Generates Revenue; Shares Climb Pre-Bell	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
Earnings Flash (KRYS) KRYSTAL BIOTECH Posts Q4 EPS $0.30, vs. Street Est of $-0.25	26/02
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
North American Morning Briefing : Traders Await Inflation Data This Week	26/02
MORNING BID AMERICAS-Booming stocks step back as PCE hoves into view	26/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Krystal Biotech, Inc.

Aandelen

KRYS

US5011471027

Andere talen

Filters